Cart
sales@molnova.com
MC-1575
CAS No. ——
MC-1575( MC1575 )
Catalog No. M17051 CAS No. ——
MC-1575 is a potent and selective class IIa HDAC inhibitor with IC50 of 440 nM for maize HD1-A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMC-1575
-
NoteResearch use only, not for human use.
-
Brief DescriptionMC-1575 is a potent and selective class IIa HDAC inhibitor with IC50 of 440 nM for maize HD1-A.
-
DescriptionMC-1575 is a potent and selective class IIa HDAC inhibitor with IC50 of 440 nM for maize HD1-A, displays >70-fold selectivity over HD1-B; exhibits a dose-dependent antiproliferative effect and induces cell cycle arrest although this blockade occurred at a different level than TSA; increases p21(waf1/CIP1) mRNA levels and induces ERbeta gene expression; also suppress IL-8 expression in human melanoma cells.
-
In Vitro——
-
In Vivo——
-
SynonymsMC1575
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight329.78
-
Molecular FormulaC18H16ClNO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(E)-3-(3-((E)-3-(3-chlorophenyl)-3-oxoprop-1-en-1-yl)-5-methylcyclopenta-1,3-dien-1-yl)-N-hydroxyacrylamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mai A, et al. J Med Chem. 2005 May 5;48(9):3344-53.
2. Duong V, et al. Mol Cancer Res. 2008 Dec;6(12):1908-19.
3. Venza I, et al. Pigment Cell Melanoma Res. 2013 Mar;26(2):193-204.
molnova catalog
related products
-
SR-18292
SR-18292 is a PPAR gamma coactivator-1α (PGC-1α) inhibitor, which increases PGC-1α acetylation, suppresses gluconeogenic gene expression and reduces glucose production in hepatocytes.
-
ACY-775
ACY-775 (ACY775) is a potent and specific HDAC6 inhibitor (IC50=7.5 nM) with improved brain bioavailability.
-
LMK-235
A selective HDAC5 and HDAC4 inhibitor with IC50 of 4.22 nM and 11.9 nM respectively.
